Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown

Purpose: The aim of this study was to analyze the impact on vision due to delay in presentation of patients requiring intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, consequent to COVID-19-related travel restrictions. Methods: Data were collected retrospectively of patie...

Full description

Bibliographic Details
Main Authors:	Manavi D Sindal, Kanika Chhabra, Vaibhav Khanna
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	age-related macular degeneration anti-vegf covid-19 diabetic macular edema retinal vein occlusion
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=730;epage=733;aulast=Sindal

Similar Items

The Major Role of Anti-Vascular Endothelial Growth Factor for Management of Macular Edema Secondary to Retinal Vein Occlusion
by: Hossam Elden Mohamed Ahmed Khalil, et al.
Published: (2021-06-01)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
by: Peng-Yao Lin, et al.
Published: (2021-12-01)

The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Clinical efficacy of intravitreous injection of Conbercept in the treatment of macular edema secondary to retinal branch vein occlusion
by: Hong-Liang Jia, et al.
Published: (2020-07-01)

Intravitreal injection of Ranibizumab combined with retinal photocoagulation for CRVO with retinal neovascularization and macular edema
by: Yong Wang
Published: (2018-06-01)

Efficacy of first Ranibizumab intravitreal injection on macular edema caused by retinal vein occlusion
by: Hong Cao, et al.
Published: (2015-09-01)

Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)

Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
by: Homayoun Nikkhah, et al.
Published: (2018-01-01)

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
by: Vincent Daien, et al.
Published: (2019-10-01)

Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association
by: V. Levent Karabaş, et al.
Published: (2022-06-01)

Efficacy of intravitreal injection of Ranibizumab combined with 577nm laser in the treatment of macular edema associated with retinal vein occlusion
by: Xue-Fei Wang, et al.
Published: (2017-12-01)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
by: Laine I, et al.
Published: (2017-11-01)

Effects of different does intravitreous triamcinolone acetonide for macular edema secondary to retinal vein occlusion
by: Jing Su, et al.
Published: (2018-08-01)

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
by: Taro Otawa, et al.
Published: (2022-06-01)

Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion–related macular edema: A systematic review and meta-analysis of randomized controlled trials
by: Qiuming Hu, et al.
Published: (2019-01-01)

Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections
by: X. Chen, et al.
Published: (2020-06-01)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
by: Andrzej Grzybowski, et al.
Published: (2021-11-01)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017-05-01)

Macular edema owing to retinal vein occlusion treated by intravitreal triamcinolone acetonide
by: Wei Liu, et al.
Published: (2013-07-01)

Study of comparison of effect and complications of intravitreal triamcinolone injection of 1 mg, 2 mg and 4 mg in macular edema of vascular origin
by: Dr. Kajal Kataria, et al.
Published: (2023-12-01)

Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series
by: Debdulal Chakraborty, et al.
Published: (2022-11-01)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
by: Rai BB, et al.
Published: (2023-06-01)

“Glaucomatous fields” after monthly intravitreal injections: Normal tension glaucoma or a mimicker?
by: Saumya M. Shah, et al.
Published: (2020-12-01)

Intravitreal injection with ranibizumab combined with triamcinolone acetonide sub-Tenon injection for macular edema due to CRVO
by: Ting-Ting Li, et al.
Published: (2015-01-01)

Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01)

Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion
by: Jing-Yi Lai, et al.
Published: (2016-04-01)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016-12-01)

Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion
by: Miao Zhao, et al.
Published: (2020-11-01)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
by: Karagiannis DA, et al.
Published: (2020-05-01)

Combined dexamethasone intravitreal implant (Ozurdex) and macular grid laser versus combined intravitreal bevacizumab and macular grid laser in branch retinal vein occlusion with macular edema
by: Abdelrahman G Salman
Published: (2015-01-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
by: A. E. Yavorskiy, et al.
Published: (2015-10-01)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016-09-01)

Safety and efficacy of Razumab – The new biosimilar in India: Our experience
by: V V Sameera, et al.
Published: (2016-01-01)

Efficacy of intravitreal injection of Ranibizumab combined with laser photocoagulation in treatment of macular edema secondary to branch retina vein occlusion
by: Rui-Fang Yang, et al.
Published: (2016-01-01)

Evaluation of early versus late intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Hesham A Enany
Published: (2018-01-01)

Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion
by: Zheng-Feng Liu, et al.
Published: (2021-05-01)

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion
by: Srijita Mitra, et al.
Published: (2021-01-01)

Intravitreous injection with ranibizumab combined laser photocoagulation for the treatment of branch retinal vein occlusion
by: Xiao-Bo Wang, et al.
Published: (2013-12-01)

Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study
by: Sahba Fekri, et al.
Published: (2022-06-01)

Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study
by: Lucas Séjournet, et al.
Published: (2023-01-01)